Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong KongLin‐Lei Chen, Kelvin Kai‐Wang To, Syed Muhammad Abdullah et al.|Nature Communications|2022Cited by 72
Omicron sublineage recombinant XBB evades neutralising antibodies in recipients of BNT162b2 or CoronaVac vaccinesXiaojuan Zhang, Kelvin Kai‐Wang To, Lin‐Lei Chen et al.|The Lancet Microbe|2022Cited by 61
Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapyXiaoxue Xie, Hong Yang, Yi Feng et al.|Bioactive Materials|2022Cited by 53
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or VaccinationLin‐Lei Chen, Kelvin Kai‐Wang To, Lu Lu et al.|Clinical Infectious Diseases|2021Cited by 51
Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccinesLu Lu, Kelvin Kai‐Wang To, Lin‐Lei Chen et al.|EBioMedicine|2022Cited by 30